Orchard Therapeutics PLC Sponsored ADR

The momentum for this stock is not very good. Orchard Therapeutics PLC Sponsored ADR is not very popular among insiders. Orchard Therapeutics PLC Sponsored ADR is a mediocre stock to choose.
Log in to see more information.
Orchard Therapeutics Plc is a biopharmaceutical company, which engages in the discovery, acquisition...
ORTX Fundamental Data by TradingView

News

Orchard Therapeutics Announces Multiple Presentations at ASGCT 2024
Orchard Therapeutics Announces Multiple Presentations at ASGCT 2024

Globe Newswire Eight presentations showcase the broad applicability of HSC gene therapy to address rare neurometabolic diseases and beyondTOKYO, LONDON and BOSTON, May 07, 2024 (GLOBE NEWSWIRE) -- Orchard...\n more…

Orchard Therapeutics Co-founder and Chief Executive Officer Dr. Bobby Gaspar Named to Inaugural 2024 TIME100 Health List
Orchard Therapeutics Co-founder and Chief Executive Officer Dr. Bobby Gaspar Named to Inaugural 2024 TIME100 Health List

Globe Newswire TOKYO, LONDON and BOSTON, May 03, 2024 (GLOBE NEWSWIRE) -- Orchard Therapeutics, recently acquired by Kyowa Kirin with the goal of accelerating the delivery of new gene therapies to patients around...\n more…

Kyowa Kirin successfully completes acquisition of Orchard Therapeutics, a global gene therapy leader for rare diseases
Kyowa Kirin successfully completes acquisition of Orchard Therapeutics, a global gene therapy leader for rare diseases

Globe Newswire Acquisition enriches Kyowa Kirin's portfolio, enables the development of numerous promising candidates with a clinically differentiated platform, and helps to resource ongoing and future launches of...\n more…

Orchard Therapeutics: Still An Attractive Merger Arbitrage Opportunity With A CVR
Orchard Therapeutics: Still An Attractive Merger Arbitrage Opportunity With A CVR

SeekingAlpha Orchard Therapeutics: Still An Attractive Merger Arbitrage Opportunity With A CVR...\n more…

Orchard Therapeutics receives Swissmedic approval for Libmeldy
Orchard Therapeutics receives Swissmedic approval for Libmeldy

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Orchard Therapeutics Receives Swissmedic Approval for Libmeldy in Early-onset MLD
Orchard Therapeutics Receives Swissmedic Approval for Libmeldy in Early-onset MLD

Globe Newswire BOSTON and LONDON, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced the Swiss Agency for Therapeutic Products (Swissmedic) has...\n more…